Prism Biolab Co (TSE:206A) Common Stock: 円1,739.8 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TSE:206A Prism Biolab Co Ltd TSE:206A
13 GF Score
Price 円147.00
! 2 Warning Signs
View Full Analysis

What is Prism Biolab Co Common Stock?

Prism Biolab Co TSE:206A -1.34% 13 Common Stock is 円1,739.8 Mil as of Mar. 2026. GuruFocus rates TSE:206A with a GF Score™ of 13/100. The stock has 2 warning signs investors should review.

Prism Biolab Co's quarterly common stock increased from Sep. 2025 (円1,730.9 Mil) to Dec. 2025 (円1,737.5 Mil) and increased from Dec. 2025 (円1,737.5 Mil) to Mar. 2026 (円1,739.8 Mil).

Prism Biolab Co's annual common stock increased from Sep. 2023 (円12.2 Mil) to Sep. 2024 (円1,714.4 Mil) and increased from Sep. 2024 (円1,714.4 Mil) to Sep. 2025 (円1,730.9 Mil).

Prism Biolab Co Common Stock Historical Data

* Premium members only.

The historical data trend for Prism Biolab Co's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Prism Biolab Co Common Stock Chart

Prism Biolab Co Annual Data
Trend Sep22 Sep23 Sep24 Sep25
Common Stock
12.25 12.25 1,714.45 1,730.91

Prism Biolab Co Quarterly Data
Sep22 Sep23 Mar24 Jun24 Sep24 Mar25 Jun25 Sep25 Dec25 Mar26
Common Stock Get a 7-Day Free Trial Premium Member Only Premium Member Only 1,729.04 1,729.04 1,730.91 1,737.51 1,739.76
TSE:206A
13GF Score
Prism Biolab Co Ltd TSE:206A
Common Stock is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Prism Biolab Co Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.

Frequently Asked Questions Learn more about Common Stock →
What does a Common Stock of 円1,739.8 Mil mean?
Prism Biolab Co (TSE:206A) has a Common Stock of 円1,739.8 Mil as of Mar. 2026. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on Prism Biolab Co and its competitors.
Is Prism Biolab Co's Common Stock too high?
Prism Biolab Co's current Common Stock is 円1,739.8 Mil. Overall, Prism Biolab Co has a GF Score™ of 13/100, reflecting its overall financial health beyond just this single metric.
How does Prism Biolab Co's Common Stock compare to VRTX and REGN?
Prism Biolab Co's Common Stock of 円1,739.8 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Common Stock for a Biotechnology company?
A good Common Stock depends on the Biotechnology industry context. However, Common Stock should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Common Stock mean?
A high Common Stock can signal that a stock is expensive relative to its fundamentals. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on Prism Biolab Co and its competitors. Prism Biolab Co's current Common Stock is 円1,739.8 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Prism Biolab Co stock overvalued right now?
Prism Biolab Co (TSE:206A) has a current Common Stock of 円1,739.8 Mil. The current Common Stock is 円1,739.8 Mil. Prism Biolab Co's overall GF Score™ is 13/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Common Stock calculated?
Common Stock is calculated from a company's financial statements. For Prism Biolab Co (TSE:206A), the current Common Stock is 円1,739.8 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Prism Biolab Co Business Description

Address 26-1, Muraoka-Higashi 2-chome, Kanagawa Prefecture, Fujisawa, JPN, 251-8555
Prism Biolab Co Ltd is engaged in drug discovery and development based on PepMetics Technology, a proprietary platform technology.
13GF Score

Get the complete analysis for TSE:206A

Common Stock is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円147.00
Price